Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
FDA approval for Structure Therapeutics' GLP-1 obesity drug by end of 2024?  | Binary | 5 | 7 months ago | ||
Market share of Structure Therapeutics' GLP-1 obesity drug by end of 2024 | Categorical | 5 | 7 months ago | ||
Structure Therapeutics' stock price at year-end 2024 | Categorical | 5 | 7 months ago | ||
Next significant milestone for Structure Therapeutics' GLP-1 obesity drug by Jun 30, 2024 | Categorical | 5 | 7 months ago | ||
Structure Therapeutics' stock price reaches $100 by Sep 30? | Binary | 4 | 7 months ago | ||
Structure Therapeutics enters into a major partnership or acquisition deal by end of 2024? | Binary | 4 | 7 months ago |